These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4033118)

  • 1. The effect of spironolactone on genital skin 5 alpha-reductase activity.
    Serafini PC; Catalino J; Lobo RA
    J Steroid Biochem; 1985 Aug; 23(2):191-4. PubMed ID: 4033118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 alpha-Reductase activity in the genital skin of hirsute women.
    Serafini P; Ablan F; Lobo RA
    J Clin Endocrinol Metab; 1985 Feb; 60(2):349-55. PubMed ID: 3965494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHT formation and degradation in cultured human skin fibroblasts: DHT accumulation in the genital skin.
    Morimoto I; Eto S; Inoue S; Izumi M; Nagataki S; Saito Y; Hara T
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):227-32. PubMed ID: 2004044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen binding capacity and 5 alpha-reductase activity in pubic skin fibroblasts from hirsute patients.
    Mowszowicz I; Melanitou E; Doukani A; Wright F; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1209-13. PubMed ID: 6841558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity.
    Paulson RJ; Serafini PC; Catalino JA; Lobo RA
    Fertil Steril; 1986 Aug; 46(2):222-6. PubMed ID: 3732528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrotestosterone stimulates 5 alpha-reductase activity in pubic skin fibroblasts.
    Mowszowicz I; Melanitou E; Kirchhoffer MO; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1983 Feb; 56(2):320-5. PubMed ID: 6218182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
    Mestayer C; Berthaut I; Portois MC; Wright F; Kuttenn F; Mowszowicz I; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1996 May; 81(5):1989-93. PubMed ID: 8626870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone 5 alpha-reductase activity of skin fibroblasts. Increase with serial subcultures.
    Mowszowicz I; Kirchhoffer MO; Kuttenn F; Mauvais-Jarvis P
    Mol Cell Endocrinol; 1980 Jan; 17(1):41-50. PubMed ID: 7358215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5 alpha-reductase activity in polycystic ovary syndrome.
    Stewart PM; Shackleton CH; Beastall GH; Edwards CR
    Lancet; 1990 Feb; 335(8687):431-3. PubMed ID: 1968168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater conversion of testosterone to 5 alpha-dihydrotestosterone, reflecting increased peripheral 5 alpha-reductase activity in nude mice treated with high doses of cyclosporine A.
    Boudou P; Fiet J; Vexiau P; Villette JM; Hardy N; Dreux C
    J Steroid Biochem; 1990 Aug; 36(6):597-601. PubMed ID: 2214776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of testosterone 5alpha-reductase in the hair follicles of women with polycystic ovaries.
    Miyazaki M; Takayasu S; Karakawa T; Aono T; Kurachi K; Matsumoto K
    J Endocrinol; 1978 Sep; 78(3):445-6. PubMed ID: 712302
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers.
    Dean HJ; Winter JS
    Steroids; 1984 Jan; 43(1):13-24. PubMed ID: 6523531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.